AP MOELLER-MAERSK AS A financial statements, including revenue, expenses, profit, and loss

The total revenue of MRSA for the last quarter is 11.35 B EUR, and it's 3.95% higher compared to the previous quarter. The net income of Q1 24 is 162.61 M EUR.